Milk Oligosaccharides Vary within Individuals and During Lactation

  • D. S. Newburg
  • P. Chaturvedi
  • C. D. Warren
  • M. Altaye
  • A. L. Morrow
  • G. M. Ruiz-Palacios
  • L. K. Pickering
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 503)

Abstract

Specific human milk oligosaccharides inhibit specific microbial pathogens.1 As soluble homologs or analogs of host receptors for pathogens, milk oligosaccharides, especially fucosylated neutral oligosaccharides, may act as decoys to protect infants against disease.2-4 To study a relationship between specific human milk oligosaccharides and disease in breast-fed infants, it is necessary to know the levels of specific oligosaccharides present in milks of individuals during lactation. Variation in total oligosaccharides, specific α1,2-linked oligosaccharides, and activities of fucosidases and fucosyltransferases has been reported.5, 6This study measures variation in individual fucosylated oligosaccharides in milks of individual mothers over the course of lactation.

Keywords

Human Milk Host Receptor Milk Oligosaccharide Human Milk Oligosaccharide Neutral Oligosaccharide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Newburg, D.S. (1996) Oligosaccharides and glycoconjugates in human milk: Their role in host defense.J. Mammary Gland Biol. Neoplasia 1, 271–283.PubMedCrossRefGoogle Scholar
  2. 2.
    Cervantes, L.E., Newburg, D.S. and Ruiz-Palacios, O.M. (1995) α1–2 Fucosylated chains (H-2 and Lewisb) are the main human milk receptor analogs forCampylobacter. Pediatr. Res.37, 171A.Google Scholar
  3. 3.
    Ruiz-Palacios, G.M., Cervantes, L.E., Newburg, D.S., Lopez-Vidal, Y. and Calva, J.J. (1992).In vitro models for studying Campylobacter jejuni infections. In Nachamkin, I., M.J. Blaser and L.S. Tomkins (eds.),Campylobacter jejuni. Current Status and Future Trends.American Society for Microbiology, Washington, D.C. pp. 176–183.7Google Scholar
  4. 4.
    Crane, J.K., Azar, S.S., Stam, A. and Newburg, D.S. (1994) Oligosaccharides from human milk block binding and activity of the Escherichia coli heat-stable enterotoxin (STa) in T84 intestinal cells.J. Nutr. 124,2358–2364.PubMedGoogle Scholar
  5. 5.
    Viverge, D., Grimmonprez, L., Cassanas, G., Bardet, L. and Solere, M. (1990) Discriminant carbohydrate components of human milk according to donor secretor types.J. Pediatr. Gastroenterol. Nutr. 11,365–370.PubMedCrossRefGoogle Scholar
  6. 6.
    Wiederschain, G.Y. and Newburg, D.S. (1995) Human milk fucosyltransferase and α-L-fucosidase activities change during the course of lactation.J. Nutr. Biochem.6,582–587.CrossRefGoogle Scholar
  7. 7.
    Coppa, G.V., Gabrielli, O., Pierani, P., Catassi, C., Carlucci, A. and Giorgi, P.L. (1993) Changes in carbohydrate composition in human milk over 4 months of lactation.Pediatrics 91,637–641.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • D. S. Newburg
  • P. Chaturvedi
  • C. D. Warren
  • M. Altaye
  • A. L. Morrow
  • G. M. Ruiz-Palacios
  • L. K. Pickering
    • 1
  1. 1.Eastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations